Company Profile

Macrocure Ltd. is a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).

Read More

NASDAQ: MCUR

$ 1.48
+ 0.01 (+0.69%)
Day High: 1.50
Day Low:  1.45
Volume:    40,703
3:58 PM ET on Jan 18, 2017

Delayed at least 20 minutes.